Literature DB >> 23880688

Nocturnal intermittent hypoxemia and metabolic dyslipidemia.

Sevket Balta1, Mehmet Aydogan2, Sait Demirkol3, Turgay Celik3, Seyfettin Gumus2, Murat Unlu3, Ugur Kucuk3.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23880688      PMCID： PMC3707178          DOI： 10.1378/chest.12-3109

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Sleep-disordered breathing and cardiovascular disease.

Authors:  Robert Wolk; Tomas Kara; Virend K Somers
Journal:  Circulation       Date:  2003-07-08       Impact factor: 29.690

2.  To maintain a proper follow-up of the patients with coronary artery disease is as nearly important as medications.

Authors:  Sait Demirkol; Mustafa Cakar; Sevket Balta; Murat Unlu; Seyit Ahmet Ay; Murat Karaman
Journal:  Int J Cardiol       Date:  2012-11-30       Impact factor: 4.164

Review 3.  Interactions between obesity and obstructive sleep apnea: implications for treatment.

Authors:  Abel Romero-Corral; Sean M Caples; Francisco Lopez-Jimenez; Virend K Somers
Journal:  Chest       Date:  2010-03       Impact factor: 9.410

4.  Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome.

Authors:  Masakazu Kono; Koichiro Tatsumi; Toshiji Saibara; Akira Nakamura; Nobuhiro Tanabe; Yuichi Takiguchi; Takayuki Kuriyama
Journal:  Chest       Date:  2007-05       Impact factor: 9.410

5.  Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia.

Authors:  Wojciech Trzepizur; Marc Le Vaillant; Nicole Meslier; Thierry Pigeanne; Philippe Masson; Marie P Humeau; Acya Bizieux-Thaminy; François Goupil; Sylvaine Chollet; Pierre H Ducluzeau; Frédéric Gagnadoux
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

6.  Independent association between obstructive sleep apnea and subclinical coronary artery disease.

Authors:  Dan Sorajja; Apoor S Gami; Virend K Somers; Thomas R Behrenbeck; Arturo Garcia-Touchard; Francisco Lopez-Jimenez
Journal:  Chest       Date:  2008-02-08       Impact factor: 9.410
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.